Gino Santini - 28 Apr 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2022
Net transactions value
-$163,412
Form type
4
Filing time
02 May 2022, 17:53:27 UTC
Previous filing
04 Jun 2021
Next filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +4,223 +9.1% 50,472 29 Apr 2022 By Trust F1
transaction HZNP Ordinary Shares Tax liability $163,412 -1,658 -3.3% $98.56 48,814 29 Apr 2022 By Trust
holding HZNP Ordinary Shares 23,795 28 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Award $0 +3,913 $0.000000 3,913 28 Apr 2022 Ordinary shares 3,913 Direct F1
transaction HZNP Restricted Stock Units Options Exercise $0 -4,223 -100% $0.000000* 0 29 Apr 2022 Ordinary shares 4,223 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.